Recurrent Gliosarcoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00279 | Liothyronine | 0 | Withdrawn | 1 |
| DB01206 | Lomustine | 0 | Withdrawn | 1 |
| DB00763 | Methimazole | 0 | Withdrawn | 1 |
| DB18630 | Allogeneic natural killer cells | 1 | Recruiting | 1 |
| DB04690 | Camptothecin | 1 | Active Not Recruiting | 1 |
| DB14844 | Dordaviprone | 1 | Withdrawn | 1 |
| DB00762 | Irinotecan | 1 | Active Not Recruiting | 1 |
| DB06448 | Lonafarnib | 1 | Active Not Recruiting | 1 |
| DB00688 | Mycophenolate mofetil | 1 | Recruiting | 1 |
| DB15721 | Natural Killer Cell | 1 | Recruiting | 1 |
| DB17178 | Tasadenoturev | 1 | Recruiting | 1 |
| DB00853 | Temozolomide | 1 | Active Not Recruiting | 1 |
| DB00853 | Temozolomide | 1 | Recruiting | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 1 / 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB16395 | Efineptakin alfa | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00853 | Temozolomide | 2 | Completed | 1 |